Hyperfine (NASDAQ:HYPR) Upgraded to "Hold" at Wall Street Zen

Key Points

• Hyperfine's stock has been upgraded from a "sell" to a "hold" rating by analysts at Wall Street Zen.
• Wells Fargo raised the company's price target from $0.68 to $0.85, while Lake Street Capital increased it from $1.50 to $2.00, indicating mixed sentiments among analysts.
• The company reported a revenue of $2.70 million last quarter, falling short of analyst estimates of $3.00 million, with a consensus EPS forecast of -0.57 for the current year.

Hyperfine (NASDAQ:HYPR - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a report issued on Saturday.

A number of other research firms have also commented on HYPR. Wells Fargo & Company raised their price objective on shares of Hyperfine from $0.68 to $0.85 and gave the company an "equal weight" rating in a research report on Friday, August 15th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Hyperfine in a research report on Wednesday, October 8th. Finally, Lake Street Capital lifted their target price on shares of Hyperfine from $1.50 to $2.00 and gave the company a "buy" rating in a research report on Thursday, August 14th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $1.28.

Hyperfine Trading Up 2.4%

HYPR stock opened at $1.28 on Friday. The firm has a 50 day moving average of $1.42 and a 200-day moving average of $1.02. Hyperfine has a 12 month low of $0.53 and a 12 month high of $2.22. The firm has a market capitalization of $100.58 million, a P/E ratio of -2.46 and a beta of 1.10.

Hyperfine (NASDAQ:HYPR - Get Free Report) last released its quarterly earnings data on Wednesday, August 13th. The company reported ($0.12) EPS for the quarter, meeting analysts' consensus estimates of ($0.12). Hyperfine had a negative net margin of 364.54% and a negative return on equity of 84.82%. The company had revenue of $2.70 million during the quarter, compared to analyst estimates of $3.00 million. Hyperfine has set its FY 2025 guidance at EPS. Sell-side analysts predict that Hyperfine will post -0.57 EPS for the current year.

Institutional Investors Weigh In On Hyperfine

An institutional investor recently bought a new position in Hyperfine stock. EP Wealth Advisors LLC bought a new stake in shares of Hyperfine, Inc. (NASDAQ:HYPR - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 34,725 shares of the company's stock, valued at approximately $25,000. Hedge funds and other institutional investors own 15.03% of the company's stock.

Hyperfine Company Profile

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.